中文摘要：

Cancer is currently one of the most important publichealth problems in the world. Pancreatic cancer is afatal disease with poor prognosis. As in most othercountries, the health burden of pancreatic cancer inChina is increasing, with annual mortality rates almostequal to incidence rates. The increasing trend ofpancreatic cancer incidence is more significant in therural areas than in the urban areas. Annual diagnosesand deaths of pancreatic cancer in China are nowbeyond the number of cases in the United States.GLOBOCAN 2012 estimates that cases in China accountfor 19.45% （65727/337872） of all newly diagnosedpancreatic cancer and 19.27% （63662/330391） ofall deaths from pancreatic cancer worldwide. Thepopulation＇s growing socioeconomic status contributesto the rapid increase of China＇s proportional contributionto global rates. Here, we present an overview of controlprograms for pancreatic cancer in China focusing onprevention, early diagnosis and treatment. In addition,we describe key epidemiological, demographic,and socioeconomic differences between China anddeveloped countries. Facts including no nationwidescreening program for pancreatic cancer, delay in earlydetection resulting in a late stage at presentation,lack of awareness of pancreatic cancer in the Chinesepopulation, and low investment compared with othercancer types by government have led to backwardnessin China＇s pancreatic cancer diagnosis and treatment.Finally, we suggest measures to improve healthoutcomes of pancreatic cancer patients in China.